News

Interleukin-2 Inhibitors Clinical Trial Pipeline Accelerates As 20+ Pharma Companies Rigorously Develop Drugs For Market Entry Delveinsight
Interleukin-2 (IL-2) inhibitors are immunosuppressive agents that block the activity of IL-2, a cytokine involved in the activation and proliferation ...
Universal stem cells reset immunity in a systemic sclerosis patient
Research led by Naval Medical University's Changzheng Hospital in China reports that an off-the-shelf cell therapy built from ...
Melanoma Pipeline Appears Robust With 150+ Key Pharma Companies Actively Working In The Therapeutics Segment Delveinsight
DelveInsight's, “Melanoma Pipeline Insight” report provides comprehensive insights about 150+ companies and 170+ pipeline ...